title: Lung cancer and lung injury: the dual role of ceramide.
abstract: Sphingolipids play key roles in cancer, yet our current understanding of sphingolipid function in lung cancer is limited to a few key players. The best characterized of these are sphingosine-1-phosphate and ceramide which are described for their opposing roles in cell fate. However, because sphingolipids as a whole are readily interconverted by a complex enzymatic machinery, no single sphingolipid appears to have exactly one role. Instead, the roles of specific sphingolipids appear to be context specific as demonstrated by findings that ceramide-1-phosphate has both proliferative and apoptotic effects depending on its concentration. Therefore, we present herein several years of research on ceramide, a sphingolipid linked to apoptotic signaling, that is emerging in cancer research for its potential roles in proliferation and cell-to-cell communication via exosomes.Ceramide is a well-studied sphingolipid in both normal and pathological conditions ranging from skin development to lung cancer. Interestingly, several groups have previously reported its increased levels in emphysema patients who are smokers, a patient subpopulation greatly susceptible to lung cancer. However, the molecular mechanisms through which cigarette smoke (CS) and ceramide accumulation lead to lung cancer, non-small cell lung cancer (NSCLC) specifically, are unknown.Interestingly, recent studies clearly establish that two signaling pathways are activated during CS exposure in the lung airway. One centers on the activation of neutral sphingomyelinase2 (nSMase2), an enzyme that hydrolyzes sphingomyelin to ceramide. The other pathway focuses on the oncogenic EGF receptor (EGFR), which becomes aberrantly activated but not degraded, leading to prolonged proliferative signaling. Recent studies show that these two signaling pathways may actually converge and integrate. Specifically, Goldkorn et al. demonstrated that during CS exposure, EGFR is favorably co-localized in ceramide-enriched regions of the plasma membrane, proposing that nSMase2/ceramide plays a role in the aberrant EGFR activation, leading to augmented tumorigenic signaling. Moreover, new findings indicate that CS exposure may induce resistance to the tyrosine kinase inhibitors (TKIs), used for treatment of NSCLC, merely through posttranslational molecular alterations. Furthermore, structural anomalies of the CS-activated EGFR appear to be supported by the excess ceramide produced by the CS-activated nSMase2 in the plasma membrane of lung epithelial cells.We present in this chapter the progression of the sphingolipid field in lung cancer using ceramide as an example. However, many crucial questions remain to be answered regarding the role of sphingolipids in lung cancer because of the glut of promising observations.
authors.affiliation: Center for Comparative Respiratory Biology and Medicine, University of California School of Medicine, Davis, CA 95616, USA. ttgoldkorn@ucdavis.edu
authors.forename: Tzipora
authors.initials: T
authors.lastname: Goldkorn
authors.forename: Samuel
authors.initials: S
authors.lastname: Chung
authors.forename: Simone
authors.initials: S
authors.lastname: Filosto
mesh_terms: D000818:Animals; D002518:Ceramides / Q000378:metabolism*; D019008:Drug Resistance, Neoplasm; D066246:ErbB Receptors / Q000235:genetics / Q000378:metabolism; D006801:Humans; D008168:Lung / Q000378:metabolism*; D055370:Lung Injury / Q000209:etiology / Q000378:metabolism* / Q000473:pathology; D008175:Lung Neoplasms / Q000188:drug therapy / Q000209:etiology / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D035683:MicroRNAs / Q000378:metabolism; D009857:Oncogenes; D018384:Oxidative Stress; D020545:Respiratory Mucosa / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects; D012907:Smoking / Q000009:adverse effects; D013108:Sphingomyelin Phosphodiesterase / Q000378:metabolism
chemical_list: D002518:Ceramides; D035683:MicroRNAs; D066246:ErbB Receptors; D013108:Sphingomyelin Phosphodiesterase
references.citation: J Cell Physiol. 2000 Sep;184(3):285-300
references.pmid: 10911359
references.citation: Nat Rev Mol Cell Biol. 2009 Feb;10(2):126-39
references.pmid: 19165215
references.citation: Nature. 2004 Nov 18;432(7015):332-7
references.pmid: 15549095
references.citation: Mol Cancer Ther. 2012 Apr;11(4):795-804
references.pmid: 22302097
references.citation: Oncogene. 2009 Apr 23;28(16):1821-32
references.pmid: 19305428
references.citation: Chest. 2007 Dec;132(6):1932-8
references.pmid: 18079226
references.citation: Chem Rev. 2011 Oct 12;111(10):6387-422
references.pmid: 21942574
references.citation: J Lipid Res. 2004 Jan;45(1):99-105
references.pmid: 14523050
references.citation: Chest. 2003 Jan;123(1 Suppl):21S-49S
references.pmid: 12527563
references.citation: Nat Cell Biol. 2008 Dec;10(12):1470-6
references.pmid: 19011622
references.citation: Cell Physiol Biochem. 2010;26(1):29-40
references.pmid: 20502002
references.citation: Int J Cancer. 2012 Apr 15;130(8):1777-86
references.pmid: 21618517
references.citation: Oncogene. 2005 Nov 17;24(51):7599-607
references.pmid: 16170374
references.citation: Science. 2002 Jul 5;297(5578):63-4
references.pmid: 12098689
references.citation: J Biol Chem. 2001 Jun 29;276(26):23954-61
references.pmid: 11287428
references.citation: Eur Respir J. 2010 Aug;36(2):417-27
references.pmid: 19926744
references.citation: FASEB J. 2008 Mar;22(3):910-7
references.pmid: 17971399
references.citation: J Biol Chem. 2001 Jun 8;276(23):20589-96
references.pmid: 11279185
references.citation: Am J Respir Cell Mol Biol. 2011 Mar;44(3):350-60
references.pmid: 20448054
references.citation: Cancer Res. 2011 Feb 1;71(3):862-72
references.pmid: 21135112
references.citation: Cell Cycle. 2009 Jul 1;8(13):2014-8
references.pmid: 19535896
references.citation: FEBS Lett. 2010 May 3;584(9):1728-40
references.pmid: 20178791
references.citation: J Lipid Res. 2007 Nov;48(11):2443-52
references.pmid: 17693623
references.citation: Am J Physiol Lung Cell Mol Physiol. 2009 Jul;297(1):L125-33
references.pmid: 19395669
references.citation: Science. 2008 Feb 29;319(5867):1244-7
references.pmid: 18309083
references.citation: Cancer Cell. 2006 Mar;9(3):189-98
references.pmid: 16530703
references.citation: Trends Cell Biol. 2012 Jan;22(1):50-60
references.pmid: 22001186
references.citation: J Biol Chem. 2004 Mar 12;279(11):9997-10004
references.pmid: 14699154
references.citation: Subcell Biochem. 2008;49:469-86
references.pmid: 18751923
references.citation: Curr Cancer Drug Targets. 2012 Jul;12(6):617-24
references.pmid: 22515519
references.citation: FASEB J. 2009 Mar;23(3):751-63
references.pmid: 19028839
references.citation: J Clin Oncol. 2011 May 20;29(15):2066-70
references.pmid: 21482987
references.citation: Biochem Pharmacol. 2006 May 14;71(10):1422-34
references.pmid: 16522318
references.citation: J Biol Chem. 2010 Jun 4;285(23):17442-52
references.pmid: 20353945
references.citation: Am J Respir Cell Mol Biol. 2000 Apr;22(4):460-8
references.pmid: 10745027
references.citation: Cancer Res. 1990 Oct 15;50(20):6731-7
references.pmid: 2145065
references.citation: Mol Cell Biol. 2009 Nov;29(21):5858-71
references.pmid: 19704002
references.citation: Cancer Sci. 2011 Dec;102(12):2157-63
references.pmid: 21895875
references.citation: Oncogene. 2003 Oct 13;22(45):7070-7
references.pmid: 14557812
references.citation: BMC Cancer. 2011 Jan 01;11:1
references.pmid: 21194487
references.citation: J Biol Chem. 2001 Sep 7;276(36):33540-6
references.pmid: 11432870
references.citation: Chest. 1989 Sep;96(3):606-12
references.pmid: 2766820
references.citation: Mol Cancer Res. 2009 Mar;7(3):393-401
references.pmid: 19240180
references.citation: J Biol Chem. 2011 Aug 12;286(32):27855-62
references.pmid: 21693702
references.citation: Am J Respir Crit Care Med. 2008 Dec 1;178(11):1100-14
references.pmid: 18755926
references.citation: Nat Clin Pract Oncol. 2008 Oct;5(10):610-8
references.pmid: 18628738
references.citation: J Biol Chem. 2012 Jan 2;287(1):514-522
references.pmid: 22074919
references.citation: Environ Health Perspect. 1985 Dec;64:111-26
references.pmid: 3007083
references.citation: Lung Cancer. 2011 May;72(2):205-12
references.pmid: 20832137
references.citation: PLoS One. 2010 Mar 23;5(3):e9826
references.pmid: 20352118
references.citation: Cancer Res. 2012 Jun 1;72(11):2855-66
references.pmid: 22472120
references.citation: Apoptosis. 2007 May;12(5):923-39
references.pmid: 17294080
references.citation: Proc Natl Acad Sci U S A. 2010 Apr 6;107(14):6328-33
references.pmid: 20304794
references.citation: Neuromolecular Med. 2010 Dec;12(4):320-30
references.pmid: 20552297
references.citation: J Lipid Res. 2011 Jan;52(1):68-77
references.pmid: 20940143
references.citation: J Biol Chem. 2010 Apr 2;285(14):10213-22
references.pmid: 20106976
references.citation: Science. 2004 Jun 4;304(5676):1497-500
references.pmid: 15118125
references.citation: CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108
references.pmid: 15761078
references.citation: J Clin Invest. 2010 Apr;120(4):1298-309
references.pmid: 20237410
references.citation: Hepatology. 2007 Oct;46(4):1166-76
references.pmid: 17668873
references.citation: Clin Cancer Res. 2009 Feb 15;15(4):1177-83
references.pmid: 19228723
references.citation: Adv Exp Med Biol. 2010;688:185-205
references.pmid: 20919655
references.citation: Eur Respir J. 1996 Apr;9(4):652-7
references.pmid: 8726926
references.citation: J Biol Chem. 1983 Mar 25;258(6):3628-31
references.pmid: 6833221
references.citation: J Biol Chem. 2001 Jul 6;276(27):24901-10
references.pmid: 11335714
references.citation: Cell Res. 2008 Oct;18(10):997-1006
references.pmid: 18766170
references.citation: Respirology. 2008 Jan;13(1):112-6
references.pmid: 18197920
references.citation: Antioxid Redox Signal. 2005 Jan-Feb;7(1-2):119-28
references.pmid: 15650401
references.citation: Am J Respir Cell Mol Biol. 2010 Sep;43(3):259-68
references.pmid: 20525802
references.citation: Mol Pharmacol. 2008 Oct;74(4):1022-32
references.pmid: 18653803
references.citation: Neurochem Res. 2007 Nov;32(11):1957-64
references.pmid: 17562162
references.citation: Nat Cell Biol. 2008 May;10(5):619-24
references.pmid: 18425114
references.citation: Science. 2004 Jun 4;304(5676):1458-61
references.pmid: 15178790
references.citation: Cancer Metastasis Rev. 2010 Mar;29(1):23-36
references.pmid: 20135199
references.citation: Future Oncol. 2010 Oct;6(10):1603-24
references.pmid: 21062159
references.citation: Biochem Biophys Res Commun. 2006 Jun 9;344(3):900-5
references.pmid: 16631623
references.citation: Biochim Biophys Acta. 2009 Jan;1788(1):178-83
references.pmid: 18786504
references.citation: Int J Cancer. 2006 Jan 15;118(2):257-62
references.pmid: 16231326
references.citation: Am J Physiol Lung Cell Mol Physiol. 2003 Jun;284(6):L1082-92
references.pmid: 12576296
references.citation: N Engl J Med. 2004 May 20;350(21):2129-39
references.pmid: 15118073
references.citation: J Biol Chem. 2002 Aug 23;277(34):31214-9
references.pmid: 12063263
references.citation: PLoS One. 2011;6(8):e23240
references.pmid: 21853092
references.citation: Proc Natl Acad Sci U S A. 2008 Jul 29;105(30):10513-8
references.pmid: 18663219
references.citation: FEBS Lett. 2007 Feb 20;581(4):735-40
references.pmid: 17274985
references.citation: Am J Respir Cell Mol Biol. 2001 Dec;25(6):676-84
references.pmid: 11726392
references.citation: J Biol Chem. 2006 May 19;281(20):14486-93
references.pmid: 16407214
references.citation: J Cell Sci. 1998 Nov;111 ( Pt 21):3209-20
references.pmid: 9763515
references.citation: Chest. 2008 Feb;133(2):343-9
references.pmid: 17951621
references.citation: Anticancer Res. 2010 Apr;30(4):1301-10
references.pmid: 20530444
references.citation: Nat Rev Clin Oncol. 2009 Oct;6(10):587-95
references.pmid: 19787002